FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Biotech Equities Technical Coverage - ZIOPHARM Oncology, Arrowhead Research, Merrimack Pharma, Vertex Pharma, and Advaxis
March 25, 2015
from PR Newswire
Advaxis Announces First Patient Treated in Phase 1/2 Dose-Escalation Study of ADXS-HPV for Recurrent Cervical Cancer
March 19, 2015
Advaxis's Lm-LLO Immunotherapy Platform to be Featured in Three Poster Presentations at the 2015 American Association for Cancer Research Annual Meeting
March 18, 2015
Advaxis Presents Preliminary Data From a Phase 1/2 Trial of ADXS-HPV in HPV-Associated Anal Cancer in Combination With Chemoradiation Showing Complete Response and No Recurrences to Date in All Treate
March 16, 2015
Gynecologic Oncology Group (GOG) Commences Enrollment in Stage 2 of GOG-0265 Clinical Trial
March 11, 2015
Mixed close despite dovish Fed
February 18, 2015
category Market News
Advaxis to Present at the 27th Annual ROTH Conference
March 05, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here